As usual, big Pharma only wants as much of your money they can get. In a recent article in USA Today on 5/28/18, Sydney Lupkin of Kaiser Health News makes that very clear. Here Goes:
“Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition by potentially stalling generic competition have raised their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis found.
As part of President’s Trump’s promise to curb high drug prices, The FDA posted a list of pharmaceutical companies that makers of …read more
Source: blogs.naturalnews.com
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr